Device company Nemera has announced the launch of a new single metered dose nasal pump called UniSpray, which is designed for delivery of systemic drugs. According to the company, UniSpray requires no priming, is compatible with standard containers, and can be used at any angle.
According to the announcement, UniSpray is a “concept under development,” and the company asserts that “Through usability analysis and Freedom to Operate assessment, we assure reliability and regulatory compliance of our unidose concept.”
Nemera VP of Strategy and Marketing Bernhard Rohn commented, “Nemera has a long-standing experience in the nasal delivery route, focusing until now on multidose pumps. Adding UniSpray to our product range provides additional options for our customers and patients, answering the needs of the single-metered dose spray combination products”
Global Category Manager, ENT, Raphaële Audibert said, “This is a great milestone for us. The increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy as well as growing adoption of self-administration practices are some of the key factors driving the growth of the nasal market.”
Read the Nemera press release.
